These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15542795)

  • 1. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
    Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
    Wiehlmann L; Cramer N; Ulrich J; Hedtfeld S; Weissbrodt H; Tümmler B
    Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.
    Clifton IJ; Peckham DG
    Expert Rev Respir Med; 2010 Aug; 4(4):519-29. PubMed ID: 20658913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics.
    Schmid J; Ling LJ; Leung JL; Zhang N; Kolbe J; Wesley AW; Mills GD; Brown PJ; Jones DT; Laing RT; Pattemore PK; Taylor DR; Grimwood K
    Eur Respir J; 2008 Dec; 32(6):1583-90. PubMed ID: 18715877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of nosocomial infections due to Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia].
    Berthelot P; Grattard F; Mallaval FO; Ros A; Lucht F; Pozzetto B
    Pathol Biol (Paris); 2005 Jul; 53(6):341-8. PubMed ID: 16004946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre.
    France MW; Dodd ME; Govan JR; Doherty CJ; Webb AK; Jones AM
    J Cyst Fibros; 2008 Sep; 7(5):368-72. PubMed ID: 18276200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic.
    Griffiths AL; Jamsen K; Carlin JB; Grimwood K; Carzino R; Robinson PJ; Massie J; Armstrong DS
    Am J Respir Crit Care Med; 2005 May; 171(9):1020-5. PubMed ID: 15709051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
    Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
    JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
    Govan JR; Brown AR; Jones AM
    Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections.
    Fothergill JL; Walshaw MJ; Winstanley C
    Eur Respir J; 2012 Jul; 40(1):227-38. PubMed ID: 22323572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit.
    Mayank D; Anshuman M; Singh RK; Afzal A; Baronia AK; Prasad KN
    Indian J Pathol Microbiol; 2009; 52(4):509-13. PubMed ID: 19805958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segregation is good for patients with cystic fibrosis.
    Conway S
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S31-5. PubMed ID: 18607016
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.
    Williams T
    Br J Biomed Sci; 1997 Sep; 54(3):181-5. PubMed ID: 9499595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation.
    Tubbs D; Lenney W; Alcock P; Campbell CA; Gray J; Pantin C
    Respir Med; 2001 Feb; 95(2):147-52. PubMed ID: 11217911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segregation and use of nonshared care settings reduce the risk of multiresistant P. aeruginosa infection. Re: Davies et al., "Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation," Pediatr Pulmonol 2003;35:253-256.
    Festini F; Ballarin S; Loganes C
    Pediatr Pulmonol; 2003 Aug; 36(2):171; author reply 172. PubMed ID: 12833499
    [No Abstract]   [Full Text] [Related]  

  • 20. Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic.
    Griffiths AL; Wurzel DF; Robinson PJ; Carzino R; Massie J
    J Cyst Fibros; 2012 Jan; 11(1):49-52. PubMed ID: 21907639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.